Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation

Journal of Hepatology
Kuen-Feng ChenAnn-Lii Cheng

Abstract

Previously we reported that Akt inactivation determines the sensitivity of hepatocellular carcinoma (HCC) cells to bortezomib. Here we report that combined treatment with sorafenib and bortezomib shows synergistic effects in HCC. HCC cell lines (PLC/PRF/5, Huh-7, and Hep3B) were treated with sorafenib and/or bortezomib and analyzed in terms of apoptosis signal transduction. In vivo efficacy was determined in nude mice with PLC/PRF/5 xenografts. Pretreatment with sorafenib enhanced bortezomib-induced apoptotic cell death by restoring bortezomib's ability to inactivate Akt in PLC/PRF/5 cells. Knocking down Akt1 by RNA-interference overcame apoptotic resistance to bortezomib in PLC/PRF/5 cells and ectopic expression of active Akt in HCC cells abolished the bortezomib sensitizing effect of sorafenib, indicating Akt inactivation plays a key role in mediating the combinational effects. Moreover, okadaic acid, a protein phosphatase 2A (PP2A) inhibitor, reversed down-regulation of phospho-Akt (P-Akt) expression induced by co-treatment with sorafenib and bortezomib, and 1, 9 di-deoxy-forskolin, a PP2A agonist, restored bortezomib's effect on P-Akt and apoptosis. Importantly, silencing of PP2A by RNA-interference reduced the apoptotic ef...Continue Reading

References

Sep 20, 2000·Proceedings of the National Academy of Sciences of the United States of America·S SatoT Tsuruo
Apr 25, 2003·British Journal of Pharmacology·Yumiko MatsuokaTakahisa Shinomiya
Nov 22, 2005·Oncogene·Jason D Arroyo, William C Hahn
Jan 13, 2006·Annual Review of Pharmacology and Toxicology·Peter M Voorhees, Robert Z Orlowski
Dec 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert C KaneRichard Pazdur
Jan 4, 2007·The Journal of Biological Chemistry·Géraldine RocherFrançoise Porteu
Jul 20, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Girija DasmahapatraSteven Grant
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Aug 14, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zheng WangZhao-You Tang
Nov 29, 2008·The Lancet Oncology·Enrique M OcioJesús F San-Miguel
Dec 5, 2008·The New England Journal of Medicine·Giancarlo Spinzi, Silvia Paggi
Jun 13, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C VerslypeC van de Velde

❮ Previous
Next ❯

Citations

Oct 12, 2010·Cancer Chemotherapy and Pharmacology·Werner J HeinzHartwig Klinker
Dec 20, 2011·Medical Molecular Morphology·Yasunobu Matsuda, Manabu Fukumoto
Jul 28, 2013·Investigational New Drugs·Shaji K KumarAlex A Adjei
Apr 28, 2012·Breast Cancer Research : BCR·Ling-Ming TsengKuen-Feng Chen
Feb 25, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Li-Li LiuChris Zhiyi Zhang
Jul 6, 2014·Critical Reviews in Oncology/hematology·Edward Ottley, Elspeth Gold
Dec 18, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Duen-Ren HouKuen-Feng Chen
Nov 17, 2011·Cancer Letters·Chao-Yuan HuangKuen-Feng Chen
Jan 29, 2011·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Hideki YokooMichiie Sakamoto
Nov 26, 2015·Journal of Advanced Pharmaceutical Technology & Research·Surekha Devadasa Shetty, Laxminarayana Kurady Bairy
Feb 1, 2012·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Tran Duc DungChih-Yang Huang
Oct 25, 2016·ACS Medicinal Chemistry Letters·Yuwei CongYubin Huang
Aug 26, 2016·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Yasunari Nakamoto
Apr 26, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jae-Kyung WonKwang-Hyun Cho
Oct 31, 2012·Laboratory Investigation; a Journal of Technical Methods and Pathology·Xiangxuan ZhaoChen Liu
Nov 27, 2018·Expert Opinion on Investigational Drugs·I-Tao HuangJason C Steel
Oct 15, 2010·Expert Review of Anticancer Therapy·Liliana MontellaSalvatore Del Prete
Oct 13, 2017·The Journal of Pharmacology and Experimental Therapeutics·Qingyu ZhouRiya Choksi
Jan 6, 2011·The Journal of Pharmacology and Experimental Therapeutics·Kuen-Feng ChenAnn-Lii Cheng
Aug 25, 2017·Science Translational Medicine·Haipeng ZhangGuangmei Yan
Jul 29, 2016·World Journal of Gastroenterology : WJG·Liliana MontellaSalvatore Del Prete
Apr 28, 2012·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Pinzhu HuangRuhai Zou
Jul 24, 2020·Acta Pharmacologica Sinica·Zhong-Jie LiGuo-Dong Lu
Mar 20, 2018·British Journal of Cancer·Ion CristóbalJesús García-Foncillas
Oct 5, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kuen-Feng ChenAnn-Lii Cheng
Jun 11, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Pinbo HuangDong Yin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.